Search results: Found 3

Listing 1 - 3 of 3
Sort by
Role of Natural Compounds in Inflammation and Inflammatory-Related Diseases

Author:
ISBN: 9783039215522 9783039215539 Year: Pages: 174 DOI: 10.3390/books978-3-03921-553-9 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Chemistry (General)
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

The papers reported here will contribute to proposing new insights into the mechanisms of several conditions, as well as suggesting new diagnostic alternatives and therapeutic targets in widespread pathologies such inflammation and inflammatory-based diseases. The discovery of the new is, as always, anchored in recourse to the old.

Research of Pathogenesis and Novel Therapeutics in Arthritis

Author:
ISBN: 9783038970651 9783038970668 Year: Pages: 366 DOI: 10.3390/books978-3-03897-066-8 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General) --- Therapeutics
Added to DOAB on : 2019-06-26 08:44:06
License:

Loading...
Export citation

Choose an application

Abstract

Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.

Keywords

biosimilars --- Th9 lymphocytes --- rheumatoid arthritis --- infliximab --- rheumatoid arthritis --- bone erosion --- osteoblasts --- next-generation sequencing --- bioinformatics --- microRNA --- messenger RNA --- osteoarthritis --- cell signaling --- IL1? --- WNT --- antagonists --- computational modeling --- nitric oxide --- clodronate --- gene expression --- osteoarthritis --- progenitor cells --- SOX9 --- spondyloarthropathies --- inflammation --- mesenchymal stem cells --- visfatin --- IL-6 --- TNF-? --- osteoarthritis --- miR-199a-5p --- Epstein-Barr virus --- glycoprotein 42 --- rheumatoid arthritis --- shared epitope --- triptolide --- rheumatoid arthritis --- basic research --- clinical translation --- osteoarthritis (OA) --- articular cartilage --- molecular pathology --- therapeutics --- rheumatoid arthritis --- antibodies --- collagen --- glycosylation --- disease pathways --- therapy --- experimental arthritis --- TNF? --- etanercept --- infliximab --- adalimumab --- certolizumab pegol --- golimumab --- rheumatoid arthritis --- therapeutic antibody --- structure --- fraxinellone --- collagen-induced arthritis --- rheumatoid arthritis --- inflammatory arthritis --- osteoclastogenesis --- sclareol --- rheumatoid arthritis --- synovial cell --- collagen --- mice --- cytokines --- Th17 --- MAPK --- arthritis --- osteoarthritis --- rheumatoid arthritis --- small-molecule inhibitor --- chondrocytes --- tumor necrosis factor-alpha --- inflammation --- rheumatoid arthritis --- osteoarthritis --- angiogenesis --- cytokines --- chemokines --- early osteoarthritis --- articular cartilage --- proliferation --- fibroblast growth factor 2 --- mitogen activated protein kinase --- transforming growth factor ? --- SMA- and MAD-related protein --- interleukin --- nuclear factor kappa B --- miRNA --- adjuvant arthritis --- arthritis --- biomarkers --- celastrol --- inflammation --- microRNA --- miRNA --- rat --- rheumatoid arthritis --- Traditional Chinese medicine --- tripterine --- triterpenoid --- spinal fusion --- biological --- osteoblast --- osteoclast --- bisphosphonate --- parathyroid hormone --- bone morphogenetic protein --- receptor activator of nuclear factor ?B --- stem cell --- drug delivery system --- anticitrullinated peptide antibodies --- antirheumatic drug --- autoimmune --- disease-modifying --- immunology --- pathology --- rheumatoid factor --- rheumatoid arthritis --- osteoarthritis --- adipokines --- obesity --- rheumatoid arthritis --- osteoarthritis --- anti-arthritis --- biomarkers

Lipopolysaccharides (LPSs)

Author:
ISBN: 9783039282562 9783039282579 Year: Pages: 390 DOI: 10.3390/books978-3-03928-257-9 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General) --- Allergy and Immunology
Added to DOAB on : 2020-04-07 23:07:08
License:

Loading...
Export citation

Choose an application

Abstract

The cytoplasm of Gram-negative bacteria is bound by three layers: an inner membrane, a layer of peptidoglycan, and an outer membrane. The outer membrane is an asymmetric lipidic bilayer, with phospholipids on its inner surface and lipopolysaccharides (LPSs) on the outside, with the latter being the major component of the outer leaflet and covering nearly three-quarters of the total outer cell surface. All LPSs possess the same general chemical architecture independently of bacterial activity (pathogenic, symbiotic, commensal), ecological niche (human, animal, soil, plant, water), or growth conditions. Endotoxins are large amphiphilic molecules consisting of a hydrophilic polysaccharide component and a covalently bound hydrophobic and highly conserved lipid component, termed lipid A (the endotoxin subunit). The polysaccharide component can be divided into two subdomains: the internal and conserved core region as well as the more external and highly variable O-specific chain, also referred to as the O-antigen due to its immunogenic properties. LPSs are endotoxins, one of the most potent class of activators of the mammalian immune system; they can be released from cell surfaces of bacteria during multiplication, lysis, and death. LPS can act through its biological center (lipid A component) on various cell types, of which macrophages and monocytes are the most important.

Keywords

aspirin --- hepcidin --- P65 (nuclear factor-?B) --- IL-6/JAK2/STAT3 pathway --- lipopolysaccharide (LPS) --- nitric oxide (NO) --- iron regulatory protein 1 (IRP1) --- Megalobrama amblycephala --- lipopolysaccharide induced TNF? factor --- lipopolysaccharide stimulation --- innate immune --- Aeromonas --- genomics --- inner core oligosaccharide --- outer core oligosaccharide --- lipopolysaccharide --- lipopolysaccharide --- Erwinia amylovora --- NMR --- ESI FT-ICR --- structural determination --- Bordetellae --- Bordetella holmesii --- endotoxin --- lipid A --- structure --- mass spectrometry --- genomic --- Edwardsiella tarda --- core oligosaccharide --- MALDI-TOF MS --- ESI MSn --- NMR --- genomic --- LPS tolerance --- hypothalamic inflammation --- insulin resistance --- pJNK --- fibroblast --- keratocyte --- cornea --- lipopolysaccharide --- bacteria --- chemokine --- adhesion molecule --- collagen --- tear fluid --- serum resistance --- complement --- Salmonella --- lipopolysaccharide --- sialic acid --- reptile-associated salmonellosis --- sepsis --- time response --- inflammation --- oxidative stress --- endotoxaemia --- mouse --- rat --- lipopolysaccharide --- double-stranded RNA --- epithelial cell --- dendritic cell --- allergic respiratory disorder --- hygiene hypothesis --- rhinovirus --- respiratory syncytial virus --- toll-like receptor --- LPS --- lipopolysaccharide --- heptosyltransferase --- protein dynamics --- glycosyltransferase --- GT-B --- inhibitor design --- lipopolysaccharide --- Coxiella burnetii --- Q fever --- phagosome --- virenose --- Plesiomonas shigelloides --- O-antigen --- lipopolysaccharide --- O-acetylation --- d-galactan I --- HR-MAS --- NMR spectroscopy --- endotoxin --- lipopolysaccharide --- Low Endotoxin Recovery --- phase transitions --- polysorbate --- LPS aggregates --- Small Angle X-ray Scattering --- MAT --- LAL and LER --- anti-conjugate serum --- core oligosaccharide --- lipopolysaccharide --- NMR spectroscopy --- ESI MS --- Proteus penneri

Listing 1 - 3 of 3
Sort by
Narrow your search

Publisher

MDPI - Multidisciplinary Digital Publishing Institute (3)


License

CC by-nc-nd (3)


Language

english (3)


Year
From To Submit

2020 (1)

2019 (2)